Company

Genovate Biotechnology Co. Ltd

Headquarters: Hsinchu City, Taiwan

Employees: 181

TWSE: 4130 +0.47%

Market Cap

TW$2.37 Billion

TWD as of Jan. 1, 2025

US$72.2 Million

Market Cap History

Genovate Biotechnology Co. Ltd Categories

Taiwan Healthcare Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Genovate Biotechnology Co. Ltd market capitalization over time

Evolution of Genovate Biotechnology Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Genovate Biotechnology Co. Ltd

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company in Taiwan. It offers central nervous system drugs, cardiovascular system drugs, musculoskeletal system drugs, immune preparation drugs, anti-infective agents, anticancer drugs, anti-viral drugs, respiratory drugs, genitourinary system drugs, and gastrointestinal drugs. The company was founded in 1995 and is based in Hsinchu, Taiwan.

Stocks & Indices

Genovate Biotechnology Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 4130 wb_incandescent

Details

Headquarters:

No. 1, Gongye 1st Road

Hsinchu Industrial Park Hukou Township

Hsinchu City, 30351

Taiwan

Phone: 886 3 5982221

Fax: 886 3 5982804